Aeglea BioTherapeutics, Inc. (AGLE) Social Stream



Aeglea BioTherapeutics, Inc. (AGLE): $0.13

0.00 (2.70%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add AGLE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#65 of 403

in industry

Featured Post From StockTwits About AGLE

ɢʟᴛᴀ.
$AGLE
** Re-post 1 hour ago **
2021-07-15 16:30 ET

Aeglea BioTherapeutics Announces Publication of 20 Week Data from Phase 1/2 and Open-Label Extension Studies of Pegzilarginase for the Treatment of Arginase 1 Deficiency in the Journal of Inherited Metabolic Disease
https://stonkmoon.com/news/AGLE/2efcc18c0556095eecd4cde1dcb70de7
Stonkmoon, published July 15, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5038 seconds.